Tag: Cancer: Ovarian
RAD51 Mutations Confer Moderate Risk of Ovarian Cancer
RAD51C and RAD51D deleterious mutations linked to increased risk of epithelial ovarian cancer
Multigene Test IDs More at Risk for Hereditary Breast/Ovarian CA
Testing for mutations other than BRCA1/2 in HBOC may change clinical management for women, families
~30 Percent With Epithelial Ovarian CA Survive Long Term
Predictors for long-term survival include younger age, early stage, low grade, non-serous histology
Intraperitoneal Chemotherapy Ups Ovarian Cancer Outcomes
However, only 41 percent of suitable candidates actually receive the therapy
Novel Pharmacological Activity for R-Ketorolac in Ovarian Cancer
R-enantiomer enriched in peritoneal fluids, inhibits peritoneal cell GTPase activity
Worse Survival With Chemo Dose Reduction in Ovarian Cancer
Lower average relative dose intensity linked to worse overall and ovarian cancer-specific survival
Benefits for Surgery Before Chemo in Advanced Ovarian CA
Appears to raise quality of life without shortening survival
Multimodal Strategy Improves Ovarian Cancer Detection
Screening using risk of ovarian cancer algorithm linked to increased number of screen-detected iEOCs
Survival Improving for Women With Ovarian Cancer
Women diagnosed today 50 percent less likely to die than they were in the 1970s
Review Examines Salpingectomy Alone for Cutting Ovarian CA Risk
Recent evidence suggests fallopian tube epithelium is origin of most high-grade serous cancers
